2c4b186c-d434-486e-8b6b-4cedfa7d7501.pdf



22 January 2016


Company Announcements Office Australian Securities Exchange 10th Floor

20 Bond Street

SYDNEY NSW 2000


Dear Sir


CONVERSION OF OPTIONS AND ISSUE OF CLEANSING PROSPECTUS


ResApp Health Limited (ASX: RAP) ("Company") advises that it has issued 18,093,750 Shares on the conversion of 18,093,750 unlisted options (exercisable at $0.026, expiring 31 December 2016) ("Options") with funds totalling

$470,437.50 having been received. 375,000 Shares issued will remain escrowed until 2 June 2016.


The Company confirms it has released a cleansing prospectus ("Prospectus") pursuant to Section 708A(11) of the Corporations Act. The purpose of the Prospectus is to remove any trading restrictions in relation to the Shares issued pursuant to the exercise of the Options.


Yours faithfully




Nicki Farley Company Secretary


ResApp Health Limited ABN 51 094 468 318

Level 24, 44 St Georges Tce, Perth WA 6000

T +61 8 6211 5099 E info@resapphealth.com.au W www.resapphealth.com.au

ResApp Health Limited issued this content on 2016-01-22 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2016-01-22 09:09:02 UTC

Original Document: http://www.resapphealth.com.au/wp-content/uploads/2016/01/1518117.pdf